A microfluidic and machine learning-enabled smartlab for autonomous remote execution and iteration of multiscale live cell assays for drug discovery
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95021C00014
- Awardee
-
Cairn Biosciences Inc. UEI LWZWY2J1M2J4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $331,500
Award facts
- Opportunity
-
- PHS202101 Solicitation number
- Contract value 100% obligated
- $331,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94158, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $331,500 |
About this award
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase I contract to Cairn Biosciences Inc., a woman-owned small business, for the development of a microfluidic and machine learning-enabled smart laboratory system for autonomous remote execution and iteration of multiscale live cell assays for drug discovery. The firm-fixed-price contract has a potential value of $331,500.00 and a completion date of June 19, 2022.
Quick answers
Who was awarded contract 75N95021C00014?
75N95021C00014 was awarded to Cairn Biosciences Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2021.
How much is contract 75N95021C00014 worth?
The government has obligated $331,500 on 75N95021C00014.
Which agency awarded contract 75N95021C00014?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021C00014, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021C00014 competed?
The extent of competition for 75N95021C00014 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award